# Intravitreal Aflibercept Injection for Radiation Retinopathy Trial

> **NCT03085784** · PHASE2 · UNKNOWN · sponsor: **Amy C Schefler, MD** · enrollment: 40 (estimated)

## Conditions studied

- Radiation Retinopathy

## Interventions

- **DRUG:** Aflibercept

## Key facts

- **NCT ID:** NCT03085784
- **Lead sponsor:** Amy C Schefler, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-05
- **Primary completion:** 2021-10
- **Final completion:** 2021-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03085784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03085784, "Intravitreal Aflibercept Injection for Radiation Retinopathy Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03085784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*